Immune Response to Fetal Calf Serum by Two Adenosine Deaminase-Deficient Patients After T Cell Gene Therapy
The DOI matches its Crossref record.
Abstract
The first approved clinical gene therapy trial for adenosine deaminase (ADA) deficiency employed autologous T cells grown in fetal calf serum (FCS)-supplemented medium and transduced with a retroviral vector (LASN) also produced in the presence of FCS. Ten years after their enrollment, both patients have circulating T cells containing vector DNA. However, whereas approximately 20% of the circulating T cells from patient 1 are still vector positive, less than 1% of patient 2's T cells have detectable vector. This difference appears to be not only a function of the original transduction efficiency and cell expansion capability in vitro, but also of the immune response that patient 2 developed to FCS components during the course of her treatment. In this study, serum samples from each patient were tested for antibodies to FCS by enzyme-linked immunosorbent assay and anti-FCS responses were demonstrated in both patients. Analysis of immunoglobulin classes revealed comparable levels of IgA and IgM anti-FCS titers. Patient 2, however, had significantly higher IgG responses to FCS than did patient 1. Investigation of the development of anti-FCS responses by IgG subclasses indicated that there was a different pattern in the development of IgG immunity to FCS between the two patients. In addition, significant antibody response to bovine lipoprotein was detected in patient 2, but not in patient 1 or in control samples. These findings suggest that the unique immune response mounted by patient 2 may have influenced the outcome of the gene transfer treatments in this patient.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Spees, J. L., Gregory, C. A., Singh, H., Tucker, H. A., Peister, A., Lynch, P. J., Hsu, S.-C., Smith, J., & Prockop, D. J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.02.012 · Cited by 509
Schallmoser, K., Bartmann, C., Rohde, E., Reinisch, A., Kashofer, K., Stadelmeyer, E., Drexler, C., Lanzer, G., Linkesch, W., & Strunk, D. (2007) · Transfusion · doi:10.1111/j.1537-2995.2007.01220.x · Cited by 503
Side effects of retroviral gene transfer into hematopoietic stem cells
Baum, C., Düllmann, J., Li, Z., Fehse, B., Meyer, J., Williams, D. A., & von Kalle, C. (2003) · Blood · doi:10.1182/blood-2002-07-2314 · Cited by 435
Kocaoemer, A., Kern, S., Klüter, H., & Bieback, K. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0627 · Cited by 414
Concise Review: Hitting the Right Spot with Mesenchymal Stromal Cells
Tolar, J., Le Blanc, K., Keating, A., & Blazar, B. R. (2010) · Stem Cells · doi:10.1002/stem.459 · Cited by 376
Immunogenicity of allogeneic mesenchymal stem cells
Schu, S., Nosov, M., O'Flynn, L., Shaw, G., Treacy, O., Barry, F., Murphy, M., O'Brien, T., & Ritter, T. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01509.x · Cited by 324
Mannello, F., & Tonti, G. A. (2007) · STEM CELLS · doi:10.1634/stemcells.2007-0127 · Cited by 309
Chen, A. K.-L., Reuveny, S., & Oh, S. K. W. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.03.006 · Cited by 292
Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use
Stute, N., Holtz, K., Bubenheim, M., Lange, C., Blake, F., & Zander, A. R. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.09.003 · Cited by 275
Baekelandt, V, Eggermont, K., Michiels, M., Nuttin, B., & Debyser, Z. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302094 · Cited by 153
Maier, D. A., Brennan, A. L., Jiang, S., Binder-Scholl, G. K., Lee, G., Plesa, G., Zheng, Z., Cotte, J., Carpenito, C., Wood, T., et al. (2013) · Human Gene Therapy · doi:10.1089/hum.2012.172 · Cited by 126
“Of more concern is the reported immune reactivity to adoptively transferred cells prepared with bovine serum, even in immunosuppressed subjects, ranging from anti–fetal calf serum (FCS) antibodies to Arthus reactions and anaphylaxis (Selvaggi et al., 1997; Mackensen et al., 2000; Horwitz et al., 2002; Tuschong et al.,…”
BackgroundTodeschi, M. R., El Backly, R., Capelli, C., Daga, A., Patrone, E., Introna, M., Cancedda, R., & Mastrogiacomo, M. (2015) · Stem Cells and Development · doi:10.1089/scd.2014.0490 · Cited by 103
“However, with regard to the present study, it should be noted that no major changes were observed in the phenotype characteristics and properties of BM-MSCs expanded in the presence of PL or FBS [34,36,39].”
Metadata
- Authors
- Tuschong, L., Soenen, S. L., Blaese, R. M., Candotti, F., & Muul, L. M.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 2002-09
- Volume
- 13
- Issue
- 13
- Pages
- 1605-1610
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W2048164516
- Cited by
- 173
- References
- 0
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.